Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATL-962 oral therapy phase 3 trial
jRCT2080220827Phase 3
- Sponsor
- Takeda
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cetilistat, sponsored by Takeda.
02
Drugs
cetilistat
Beyond the preview
Go deeper on jRCT2080220827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220827.